EAST BRUNSWICK, N.J., Sept. 10, 2018 /PRNewswire/ -- Grace Therapeutics, a clinical stage biopharmaceutical company focused on rare and orphan diseases, announcedtoday that it is scheduled to speak at the Morgan Stanley Annual Global Healthcare Conference in New York City.
Dr. Bruce Hochstadt, Chief Operating Officer, and Prashant
About Grace Therapeutics
Grace Therapeutics, Inc. is an innovative biopharmaceutical company focused on rare and orphan diseases. Grace utilizes unique delivery technologies in developing novel product formulations to address critical unmet needs.
Grace's development pipeline consists of five product candidates focused primarily on Central Nervous System diseases. Clinical studies are ongoing for three of these late stage assets, with the remaining two advancing toward the clinic. The company is pursuing multiple commercialization options for these products for maximum value creation in its path to becoming a fully integrated commercial and marketing organization.
Headquartered in East Brunswick, New Jersey, privately held Grace has strategic agreements with pre-eminent partners in contract research, manufacturing and market development. To learn more, visit www.gtrx.com.
View original content:http://www.prnewswire.com/news-releases/grace-therapeutics-to-present-at-the-morgan-stanley-global-healthcare-conference-300708889.html
SOURCE Grace Therapeutics
Subscribe to our Free Newsletters!
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...
Are you gluten intolerant? Stay away from gluten allergy and celiac disease by shifting to ...
Moxetumomab pasudotox-tdfk is used to treat hairy cell leukemia (a form of chronic lymphocytic ...View All